Quantifying Value in Health: The (New) SWIFT Paradigm is the kind of topic that looks straightforward until it collides with the speed, ambiguity, and competing demands of clinic sessions and day-to-day service delivery. In Quantifying Value in Health: The (New) SWIFT Paradigm, for this course, the practical stakes show up in safe, humane intervention that respects health variables and daily-life feasibility, not in abstract discussion alone.
Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →Health economists, payers, providers, and pharmaceutical executives rely on an ever-growing body of evidence to make investment, reimbursement, and care decisions. In oncology, this entails assimilating and analyzing an ever-growing flood of clinical trial and real-world data in a treatment landscape that can change drastically in a matter of months. Given recent developments in AI technology, stakeholders have increasingly adopted a SWIFT (Systematic Workflow for Immediate, Frequent, and Transparent data) paradigm towards evidence management, with a mind towards driving replicable clinical models, study protocols, and evidence synthesis to support decision making. For manufacturers, this entails the creation of living, dynamic repositories of clinical trial and real word data, while public and private payers alike are streamlining their P & T/formulary decision-making process and driving digital access to clinical policy reports. Topics to be discussed: AI for Trial Design, RWE, Health Technology Assessment, Systematic Literature Review and Meta-analysis.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Norm is currently the CEO of Patient Discovery where he is responsible for leading the company through all aspects of operations, strategy and growth. Prior to co-founding Patient Discovery, Norm was part of the founding team and CFO of True Office, the ground-breaking adaptive learning and behavioral analytics compliance solution currently used by millions of employees across the Fortune 1000. In 2014, True Office was acquired by Intercontinental Exchange (NYSE:ICE), the parent company of the New York Stock Exchange. At NYSE, Norm was responsible for leading Sales and Business Development. Prior to True Office, Norm lead two private equity-backed business: Yankee Group Research and Pharmedica. Jason spent many years at global roles within Unilever, including a CFO role at a Unilever joint venture with a publicly traded Israeli company. With over two decades of leading teams through periods of high growth, Norm brings a wealth of operational and commercial experience to Patient Discovery.
Dig into the research behind this topic — plain-English summaries written for BCBAs.
279 research articles with practitioner takeaways
252 research articles with practitioner takeaways
236 research articles with practitioner takeaways
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.